GlobeNewswire by notified

DOVRE GROUP TRADING STATEMENT JANUARY 1 – SEPTEMBER 30, 2023

Share

Dovre Group Plc                Stock exchange release        October 26, 2023, at 8.45 a.m.  

DOVRE GROUP TRADING STATEMENT JANUARY 1 – SEPTEMBER 30, 2023


Dovre Group Plc issues today a trading statement for the three months ended on September 30, 2023.The figures presented in this trading statement are not audited. Last year’s corresponding period in parentheses. 

July – September 2023 

  • Net sales EUR 52.8 (59.7) million – decrease of -11.6%.  
    • Project Personnel: net sales EUR 28.8 (22.5) million – increase of 28.2%.  
    • Consulting: net sales EUR 3.5 (4.4) million – decrease of -19.7%.  
    • Renewable Energy: net sales EUR 20.5 (32.9) million – decrease of -37.8%.  
  • EBITDA EUR 2.9 (3.2) million – decrease of -7.2%.  
  • Operating profit EUR 2.7 (3.0) million – decrease of -12.1%.   
  • Profit before tax EUR 2.1 (2.9) million – decrease of -26.2%.  
  • Profit for the shareholders of the parent company EUR 1.3 (1.9) million – decrease of -31.6%.  
  • Earnings per share EUR 0.012 (0.018) – decrease of -32.6%.  
  • Net cash flow from operating activities EUR -3.3 (0.6) million.  

January – September 2023 

  • Net sales EUR 145.9 (154.9) million – decrease of -5.8%.  
    • Project Personnel: net sales EUR 79.5 (67.6) million – increase of 17.6%.  
    • Consulting: net sales EUR 12.6 (13.3) million – decrease of -5.5%.  
    • Renewable Energy: net sales EUR 53.8 (73.9) million – decrease of -27.2%.  
  • EBITDA EUR 6.6 (7.0) million – decrease of -4.8%.
  • Operating profit EUR 5.9 (6.3) million – decrease of -6.7%.   
  • Profit before tax EUR 4.9 (6.0) million – decrease of -18.8%.  
  • Profit for the shareholders of the parent company EUR 3.1 (4.1) million – decrease of -24.0%. 
  • Earnings per share EUR 0.029 (0.039) – decrease of -25.6%.  
  • Net cash flow from operating activities EUR 3,8 (0.0) million.  


Outlook for 2023 unchanged (issued on 26 June 2023):

Dovre Group’s net sales in 2023 are expected to be in the range of 185 to 195 million Euros and the operating profit (EBIT) is expected to be above 7.0 million.   

ARVE JENSEN, CEO:

In Q3 2023, Dovre Group posted total net sales of EUR 52.8 million, reflecting an 11.6% decrease compared to the same period in 2022. Year-on-year fluctuations in foreign currency exchange rates, particularly the Norwegian krone, had an impact on the Group’s net sales in Q3. At fixed rates, the net sales decreased by 6.4%.

Our Project Personnel segment was the outstanding performer in Q3 and reported a remarkable 28.2% increase in net sales compared to Q3 2022. By contrast, the Consulting segment reported a 19.7% decrease and Renewable Energy experienced a 37.8% decrease in net sales during Q3 2023.

A ransom attack on our Norwegian operations in late September impacted our financial systems and operational directories. We have successfully recovered from this incident without interruption to our services and we used this opportunity to move our financial systems to be cloud-based. This will yield lower costs for the financial function in Norway starting from Q4/2023.

Despite challenges posed by the weak Norwegian currency and new labor legislation, our Project Personnel division maintained robust growth. Meanwhile, our Canadian operations remained active, particularly with a major biodiesel refinery project. In the Consulting sector, the comparison period in 2022 was at an all-time high, but we have since leveled down from that peak. This notwithstanding, the Norwegian consulting unit signed a new multi-year framework agreement with the Ministry of Finance.

The Finnish wind farm construction market's sluggish performance in 2023 affected Suvic’s operations throughout the year. However, Suvic had already diversified its scope in 2022 to encompass other renewable business areas, thus securing new projects such as the Fortum heat-exchange power plant in Kirkkonummi and an "early works contract" for two large wind farms in Sweden during Q3.

Varied performance between the three segments is a natural part of our business landscape. These fluctuations can be attributed to market cycles, project timelines, and related factors. They also highlight the need for continuous adaptability, prudent risk management, and strategic foresight. 


NET SALES

Net sales in Q3

In Q3, Dovre Group’s net sales decreased by -11.6% to EUR 52.8 (59.7) million.  

Project Personnel accounted for 54 (38) %, Consulting for 7 (7) %, and Renewable Energy for 39 (55) % of the Group’s net sales.

Project Personnel’s net sales increased by 28.2% to EUR 28.8 (22.5) million, while net sales for Consulting decreased by -19.7% to EUR 3.5 (4.4) million. Net sales in Renewable Energy were also down by -37.8% to 20.5 (32.9) million euros.  

Net sales by reporting segment

7–9


7–9


Change


1–9


1–9


Change


1–12
EUR million 20232022%20232022%2022
Project Personnel 28.8  22.5  28.2   79.567.6 17.6 90.6  
Consulting 3.5  4.4  -19.7  12.6 13.3 -5.5 18.2  
Renewable Energy 20.5  32.9  -37.8  53.8 73.9 -27.2 94.2  
Group total 52.859.7-11.6145.9154.9-5.8 203.0  

OPERATING PROFIT

Profitability in Q3

The Group’s EBITDA in Q3 decreased by -7.2% to EUR 2.9 (3.2) million. The Group’s operating profit decreased by -12.1% to EUR 2.7 (3.0) million. Project Personnel’s operating profit was EUR 1.7 (1.1) million, Consulting’s operating profit was EUR 0.4 (0.7) million and Renewable Energy’s operating profit was EUR 0.9 (1.4) million. In Renewable Energy, the weakened Q3 profitability year-on-year was attributable to the difference in portfolio of projects. The operating loss of the Group’s Other functions was -0.2 (-0.2) million.   

EBITDA

7–9


7–9


Change


1–9


1–9


Change

1–12
EUR million 20232022%20232022%2022
Project Personnel 1.8  1.2  59.0  4.2 3.4 21.6 4.7  
Consulting 0.4  0.7  -42.5  1.3 1.6 -19.5 2.5  
Renewable Energy 0.9  1.5  -36.2  1.7 2.4 -27.8 2.9  
Other Functions -0.2  -0.1  -39.2  -0.6 -0.4 -33.3 -0.7  
Unallocated * 0.0  0.0  159.3  0.0 -0.1 75.2 0.0  
Group total 2.93.2-7.2 6.6 7.0-4.8 9.5 


Operating profit

7–9


7–9


Change


1–9


1–9


Change

1–12
EUR million 20232022%20232022%2022
Project Personnel 1.7  1.1  53.7  3.8 3.2 20.0 4.3  
Consulting 0.4  0.7  -42.6  1.3 1.6 -19.0 2.5  
Renewable Energy 0.9  1.4  -43.9  1.6 2.3 -31.9 2.7  
Other Functions -0.2  -0.2  -34.2  -0.6 -0.5 -28.7 -0.7  
Unallocated * -0.1  -0.1  8.4  -0.2 -0.3 39.2 -0.3  
Group total 2.7  3.0-12.15.9 6.3 -6.7 8.5  

*Unallocated expenses include amortization of customer agreements and relations.

PERSONNEL

In Q3 2023, the average number of employees increased by 14.4% year-on-year. During January–September, Dovre Group employed an average of 833 people (789). The average number of employees during the period increased due to the organic growth of the Project Personnel and Renewable Energy business areas.  

On September 30, 2023, Dovre Group employed 900 (708) people, 746 (563) of whom were employed by Project Personnel, 95 (101) by Consulting, 57 (42) by Renewable Energy and 2 (2) by Other functions.   



Average number of personnel


7–9


7–9

Change


1–9


1–9


Change

1–12
20232022%20232022%2022
Project Personnel 723  619  16.8  682 653 4.4 642  
Consulting 93  99  -6.4  100 97 2.7 98  
Renewable Energy 54  42  28.6  49 36 34.5 38  
Other Functions 2  2  0.0  0.0 1  
Group total 87276214.4 833 7895.6 779
Personnel at period-end

30.9.


30.9.


Change


31.12.
20232022%2022
Project Personnel  746  563  32.6  583  
Consulting  95  101  -5.9  100  
Renewable Energy*  57  42  35.7  43  
Other Functions  2  2  0.0  2  
Group total 900 70827.2 728 

CASH POSITION

On September 30, 2023, the Group’s net debt was EUR -1.7 (1.3) million. The Group’s cash and cash equivalents totaled EUR 9.2 (7.9) million. The Group’s interest-bearing liabilities were EUR 7.5 (9.2) million, a total of EUR 5.8 (6.2) million of which were current and EUR 1.7 (3.0) million non-current.   

In January – September, net cash flow from operating activities totaled EUR 3.8 (0.0) million, which includes EUR 0.7 (-5.6) million change in working capital. The increase in working capital is mainly due to the decrease in the total amount of advance payments from projects in progress.   

In Espoo, October 26, 2023  

DOVRE GROUP PLC  
BOARD OF DIRECTORS  

For additional information, please contact:  

Dovre Group Plc  
Arve Jensen, CEO  
tel.  +47 90 60 78 11  
arve.jensen@dovregroup.com  


Distribution
Nasdaq Helsinki Ltd  
Major media  
www.dovregroup.com

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Dassault Aviation Wins Choiseul “Strategic Company” Award29.11.2023 10:21:57 CET | Press release

Dassault Aviation Wins Choiseul “Strategic Company” Award (Saint-Cloud, November 29, 2023) – Dassault Aviation is particularly proud to have received the 2023 Strategic Company Award as part of the Institut Choiseul’s Sovereignty Initiative. The institute believes that strategic companies represent one of the many facets of national strength. Award recipients are known for their capacity to effectively mobilize resources and know-how, and to provide solutions that meet national priorities. They are a cornerstone of French strategic heritage. Dassault Aviation is an industrial architect and complex systems integrator, a developer of strategic technologies, a major national exporter, a core shareholder of the Thales Group and a vital player in an industrial landscape that includes hundreds of business and service partners. The company is at the core of the French sovereign defense ecosystem. Dassault Aviation is also the only non-American company that manufactures high-end business jets.

Company announcement no 17/2023 Interim Report Q3 202329.11.2023 10:20:00 CET | Press release

Interim Report Q3 2023 EBITDA fixed herd prices (FHP) for Q3 2023 increased to 13.663 mEUR (Q3 2022: 10.463 kEUR), corresponding to an EBITDA margin FHP of 36.3% (Q3 2022: 32.5%). The quarterly EBITDA in Q3 2023 increased by 3.201 kEUR (compared to Q3 2022). Nevertheless, this consist of many parts this quarter: Russia harvest negative with 2,7 mEUR (from 4,1 to 1,5 mEUR) whereas remaining Russian business compensate positive with 3,0 mEUR partly due to FX (cost in EUR lower), Lithuania negative effects from one-off subsidy in Q3 2022 (2,5 mEUR), but combined sales/feed with positive effect of 4.9 mEUR and lower cost levels with 0.5 mEUR driven by utilities. Sales prices combined down, as they in Q3 2023 were 1.59 EUR/kg live weight, down from 1.62 EUR/kg Q2 2022 equal to EUR 0,8m, but EURRUB effects this picture highly as Lithuanian sales prices in EUR is up 23% and Russian in RUB is up 13%. Feed prices in Q3 2023 were 261 EUR/T (compared to 332 EUR/T Q3 2022). End September 2023 on h

Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT05, a Proposed Biosimilar for Simponi® and Simponi Aria®29.11.2023 10:00:00 CET | Press release

The study, assessing pharmacokinetics, safety, and tolerability of AVT05 compared to Simponi® (golimumab) in healthy adult subjects, met its primary endpoint Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today positive top-line results from a pharmacokinetic study for AVT05, a biosimilar candidate to Simponi® and Simponi Aria® (golimumab). The study, which assessed the pharmacokinetics, safety, and tolerability of AVT05 compared to Simponi in healthy adult subjects, met its primary endpoints. “These results demonstrate the strength of our platform approach to biosimilars development and manufacture, combining a well-designed and executed clinical study with the design of a high-quality manufacturing process and strong analytical capabilities,” said Joseph McClellan, Chief Scientific Officer. “As we progress more biosimilar candidates through clinical development and approval, w